Related references
Note: Only part of the references are listed.Cucurbituril-Ferrocene: Host-Guest Based Pretargeted Positron Emission Tomography in a Xenograft Model
Vilma I. J. Jallinoja et al.
BIOCONJUGATE CHEMISTRY (2021)
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
Vilma I. J. Jallinoja et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses
Sarah M. Cheal et al.
THERANOSTICS (2020)
Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting
Kristina Westerlund et al.
BIOMATERIALS (2019)
Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines
E. Johanna L. Steen et al.
BIOMATERIALS (2018)
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric Ovacik et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma
Rosemery Membreno et al.
MOLECULAR PHARMACEUTICS (2018)
Supramolecular complexes for nanomedicine
Chiara M. A. Gangemi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Exploring Structural Parameters for Pretargeting Radioligand Optimization
Jan-Philip Meyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pretargeted Imaging and Therapy
Mohamed Altai et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Pretargeting for imaging and therapy in oncological nuclear medicine
Clement Bailly et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2017)
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
Jacob L. Houghton et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Cucurbituril-Based Molecular Recognition
Steven J. Barrow et al.
CHEMICAL REVIEWS (2015)
Cucurbiturils: from synthesis to high-affinity binding and catalysis
Khaleel I. Assaf et al.
CHEMICAL SOCIETY REVIEWS (2015)
Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics
Brian M. Zeglis et al.
MOLECULAR PHARMACEUTICS (2015)
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
Rafke Schoffelen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Trans-Cyclooctene Tag with Improved Properties for Tumor Pretargeting with the Diels-Alder Reaction
Raffaella Rossin et al.
MOLECULAR PHARMACEUTICS (2014)
Highly Reactive trans-Cyclooctene Tags with Improved Stability for Diels-Alder Chemistry in Living Systems
Raffaella Rossin et al.
BIOCONJUGATE CHEMISTRY (2013)
Diels-Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
Raffaella Rossin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Molecular Recognition of Insulin by a Synthetic Receptor
Jordan M. Chinai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study
Vanya D. Uzunova et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Michael M. Schmidt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma
A Forero et al.
BLOOD (2004)
Humanization of the anti-CEA T84.66 antibody based on crystal structure data
PJ Yazaki et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Share Paper
